Benzinga | May 26, 2021 08:29AM EDT

Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $290

Morgan Stanley analyst Meta Marshall maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $338 to $290.